NeuroSense Therapeutics Ltd. (NRSN)

NCM – Real Time Price. Currency in USD

0.45

-0.02 (-5.25%)

Market open: Aug 12, 2026, 10:07 AM EDT

0.47

-0.00 (-0.30%)

Previous after-hours: Aug 11, 2026, 6:21 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

06.08.2026

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

Final meeting minutes reflect alignment with Health Canada on the planned content and structure of the ALS submission CAMBRIDGE, Mass., Aug. 6, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd.

Videos

No Data

There is no data to display

Press releases

06.08.2026

NeuroSense Therapeutics Ltd. (NRSN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

NeuroSense Therapeutics Ltd. (NRSN)

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

Videos

No Data

Press releases

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

Videos

No Data

Press releases

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

Search stocks

NeuroSense Therapeutics Ltd. (NRSN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

NeuroSense Therapeutics Ltd. (NRSN)

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

Videos

No Data

Press releases

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

Videos

No Data

Press releases

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada